EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

What is the Reason That the Pharmacological Future of Chemotherapeutics in the Treatment of Lung Cancer Could Be Most Closely Related to Nanostructures? Platinum Drugs in Therapy of Non-Small and Small Cell Lung Cancer and Their Unexpected, Possible Interactions. The Review

Kamil Szupryczyński, Przemysław Czeleń, Tomasz Jeliński, Beata Szefler iD

International Journal of Nanomedicine · 2024

DOI: 10.2147/ijn.s469217 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2024. Verfasst von Kamil Szupryczyński und 3 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School of Medical and Health Sciences, Faculty of Pharmacy, Collegium Medicum, Nicolaus, Copernicus University, Bydgoszcz, Poland. Hauptthemen laut MEDLINE: Lung Neoplasms, Antineoplastic Agents, Nanostructures, Nanomedicine. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 485 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsAntineoplastic AgentsNanostructuresNanomedicineCarcinoma, Non-Small-Cell LungHumansSmall Cell Lung CarcinomaDrug Interactions

Stichwörter der Autor:innen

carboplatincisplatindrug deliveryfullerenesnanoparticlesnanotubenedaplatinoxaliplatinpersonalized medicineplatinum-based drugs

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Doctoral School of Medical and Health Sciences, Faculty of Pharmacy, Collegium Medicum, Nicolaus, Copernicus University, Bydgoszcz, Poland.
  • Department of Physical Chemistry, Faculty of Pharmacy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland.

ORCID-Profile: Beata Szefler

Zitieren

APA

Szupryczyński, K., Czeleń, P., Jeliński, T., & Szefler, B. (2024). What is the Reason That the Pharmacological Future of Chemotherapeutics in the Treatment of Lung Cancer Could Be Most Closely Related to Nanostructures? Platinum Drugs in Therapy of Non-Small and Small Cell Lung Cancer and Their Unexpected, Possible Interactions. The Review. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s469217

Vancouver

Szupryczyński K, Czeleń P, Jeliński T, Szefler B. What is the Reason That the Pharmacological Future of Chemotherapeutics in the Treatment of Lung Cancer Could Be Most Closely Related to Nanostructures? Platinum Drugs in Therapy of Non-Small and Small Cell Lung Cancer and Their Unexpected, Possible Interactions. The Review. International Journal of Nanomedicine. 2024. doi:10.2147/ijn.s469217

BibTeX
@article{Szupryczyski2024,
  author = {Szupryczyński, Kamil and Czeleń, Przemysław and Jeliński, Tomasz and Szefler, Beata},
  title = {What is the Reason That the Pharmacological Future of Chemotherapeutics in the Treatment of Lung Cancer Could Be Most Closely Related to Nanostructures? Platinum Drugs in Therapy of Non-Small and Small Cell Lung Cancer and Their Unexpected, Possible Interactions. The Review},
  journal = {International Journal of Nanomedicine},
  year = {2024},
  doi = {10.2147/ijn.s469217}
}
Kostenlos starten →